Comment on: “Objectification of Skin Glow: In Vivo Evaluation of 300 Women in Relation to Age”
Moeeza Fatima, Husnain Ahmad, Fatima Qasim, Isha Munir

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSkin Protection and Aging · Dermatologic Treatments and Research · melanin and skin pigmentation
Dear Editor,
We read with great interest the recent article by Roessle and Kerscher, which represents a noteworthy contribution towards understanding and objectifying the concept of skin glow [1]. Their in vivo evaluation of 300 women in relation to age offers valuable insights into this complex trait. While the study provides proper preliminary reference values, several limitations were not sufficiently addressed and warrant further consideration to improve the applicability and generalizability of the findings.
First, while the study restricts participants to Fitzpatrick skin types I–IV, the exclusion of individuals with darker phototypes significantly limits the ability to generalize the findings. Ethnic differences in skin characteristics, such as melanin distribution, vascular reactivity, and light scattering properties, can affect how skin glow is perceived and measured. Studies have shown that darker skin types exhibit distinct patterns of pigmentation and erythema [2, 3]. Given that this study is based on a narrow range of phototypes, the conclusions may not apply to broader, more diverse populations. Since this is a short study with an exploratory design, it is crucial to acknowledge the ethnic limitations and suggest that future studies include a wider range of skin types to make the findings more inclusive and applicable.
Second, the study's exclusive focus on female participants limits the applicability of the results. While sex differences in skin physiology are well documented (particularly in terms of sebum secretion and vascular activity), the exclusion of males from this study leaves a gap in understanding how these findings may translate across genders [4]. This limitation should be addressed, as it reduces the external validity of the study. Short studies, such as the one presented, typically have more targeted samples. Still, it is critical to highlight the importance of including both males and females in future research to ensure balanced representation.
Third, the anatomical sites measured may not optimally reflect clinically relevant glow‐related changes. Lateral cheek measurements, for example, may underestimate centrofacial aging patterns, where pigmentation and telangiectasia are most pronounced [5]. Similarly, neck and décolleté readings are influenced by clothing and cultural behaviors, limiting universal applicability. Lastly, the study omitted molecular and structural markers that strongly influence glow. Studies have shown that advanced glycation end‐products (AGEs), collagen integrity, and oxidative stress biomarkers are known to alter skin radiance independent of erythema or melanin indices [6, 7]. Their exclusion narrows the biological interpretation of the findings.
Looking forward, several advancements could address these gaps. High‐resolution imaging modalities, such as hyperspectral imaging and AI‐driven skin analysis, can now quantify complexion heterogeneity and radiance more precisely [8]. In vivo Raman spectroscopy allows non‐invasive detection of AGEs, offering mechanistic insights. On the therapeutic front, next‐generation hybrid fillers (e.g., CPM‐HA20G) and biostimulatory injectables have shown sustained improvements across multiple skin quality domains, including glow [9]. Integrating these approaches with lifestyle‐adjusted, longitudinal data would provide a more comprehensive and clinically meaningful framework.
While Roessle and Kerscher provide valuable preliminary benchmarks for skin glow, the study's limited phototype range, female‐only cohort, single‐visit design, assumptions regarding missing data, site‐selection issues, lack of reproducibility testing, and omission of mechanistic biomarkers constrain its interpretability and generalisability. Future studies should adopt broader, longitudinal, and multimodal approaches to establish robust, inclusive, and clinically relevant standards for skin glow assessment.
Author Contributions
Moeeza Fatima and Husnain Ahmad conceived the idea, reviewed the original article, performed the literature search, and drafted the manuscript. Fatima Qasim and Isha Munir reviewed and approved the final version of the letter.
Ethics Statement
The authors have nothing to report.
Consent
The authors have nothing to report.
Conflicts of Interest
The authors declare no conflicts of interest.
Linked Articles
This article is linked to Roessle and Kerscher paper. To view this article, visit https://doi.org/10.1111/jocd.70373.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1A. Roessle and M. Kerscher , “Objectification of Skin Glow: In Vivo Evaluation of 300 Women in Relation to Age,” Journal of Cosmetic Dermatology 24, no. S 4 (2025): e 70373.40847899 10.1111/jocd.70373 PMC 12374564 · doi ↗ · pubmed ↗
- 2A. V. Rawlings , “Ethnic Skin Types: Are There Differences in Skin Structure and Function?,” International Journal of Cosmetic Science 28, no. 2 (2006): 79–93.18492142 10.1111/j.1467-2494.2006.00302.x · doi ↗ · pubmed ↗
- 3B. Nedelec , N. J. Forget , T. Hurtubise , et al., “Skin Characteristics: Normative Data for Elasticity, Erythema, Melanin, and Thickness at 16 Different Anatomical Locations,” Skin Research and Technology 22, no. 3 (2016): 263–275.26333046 10.1111/srt.12256 · doi ↗ · pubmed ↗
- 4E. D. Lephart and F. Naftolin , “Factors Influencing Skin Aging and the Important Role of Estrogens and Selective Estrogen Receptor Modulators (SER Ms),” Clinical, Cosmetic and Investigational Dermatology 15 (2022): 1695–1709, 10.2147/CCID.S 333663.36017417 PMC 9397534 · doi ↗ · pubmed ↗
- 5M. A. Nilforoushzadeh , M. A. Amirkhani , P. Zarrintaj , et al., “Skin Care and Rejuvenation by Cosmeceutical Facial Mask,” Journal of Cosmetic Dermatology 17, no. 5 (2018): 693–702.30133135 10.1111/jocd.12730 · doi ↗ · pubmed ↗
- 6C. Jeanmaire , L. Danoux , and G. Pauly , “Glycation During Human Dermal Intrinsic and Actinic Ageing: An In Vivo and In Vitro Model Study,” British Journal of Dermatology 145, no. 1 (2001): 10–18.11453901 10.1046/j.1365-2133.2001.04275.x · doi ↗ · pubmed ↗
- 7A. F. M. Pereira , B. V. M. Rodrigues , L. M. Neto , et al., “Confocal Raman Spectroscopy as a Tool to Assess Advanced Glycation End Products on Solar‐Exposed Human Skin,” Vibrational Spectroscopy 114 (2021): 103234.
- 8Y. H. El‐Sharkawy , “Advancements in Non‐Invasive Hyperspectral Imaging: Mapping Blood Oxygen Levels and Vascular Health for Clinical and Research Applications,” Vascular Pharmacology 155 (2024): 107380.38806138 10.1016/j.vph.2024.107380 · doi ↗ · pubmed ↗
